<VariationArchive RecordType="classified" VariationID="1319982" VariationName="NM_001330700.2(TOP2B):c.1776_1778del (p.Glu593del)" VariationType="Deletion" Accession="VCV001319982" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-11-11" MostRecentSubmission="2021-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1310230" VariationID="1319982">
      <GeneList>
        <Gene Symbol="TOP2B" FullName="DNA topoisomerase II beta" GeneID="7155" HGNC_ID="HGNC:11990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="25597905" stop="25664907" display_start="25597905" display_stop="25664907" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="25639474" stop="25705787" display_start="25639474" display_stop="25705787" Strand="-" />
          </Location>
          <OMIM>126431</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001330700.2(TOP2B):c.1776_1778del (p.Glu593del)</Name>
      <CanonicalSPDI>NC_000003.12:25629056:TCTTC:TC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="25629057" stop="25629059" display_start="25629057" display_stop="25629059" variantLength="3" positionVCF="25629056" referenceAlleleVCF="CTCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="25670548" stop="25670550" display_start="25670548" display_stop="25670550" variantLength="3" positionVCF="25670547" referenceAlleleVCF="CTCT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>3-BP DEL, 1761AGA</Name>
      </OtherNameList>
      <ProteinChange>E588del</ProteinChange>
      <ProteinChange>E593del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.25670550_25670552del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.25670550_25670552del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.25629059_25629061del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.25629059_25629061del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052961.1" sequenceAccession="NG_052961" sequenceVersion="1" change="g.40314_40316del">
            <Expression>NG_052961.1:g.40314_40316del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001068.3" sequenceAccession="NM_001068" sequenceVersion="3" change="c.1761_1763del">
            <Expression>NM_001068.3:c.1761_1763del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001059.2" sequenceAccession="NP_001059" sequenceVersion="2" change="p.Glu588del">
            <Expression>NP_001059.2:p.Glu588del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330700.2" sequenceAccession="NM_001330700" sequenceVersion="2" change="c.1776_1778del" MANESelect="true">
            <Expression>NM_001330700.2:c.1776_1778del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317629.1" sequenceAccession="NP_001317629" sequenceVersion="1" change="p.Glu593del">
            <Expression>NP_001317629.1:p.Glu593del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001068.3" sequenceAccession="NM_001068" sequenceVersion="3" change="c.1761_1763delAGA">
            <Expression>NM_001068.3:c.1761_1763delAGA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="126431.0001" DB="OMIM" />
        <XRef Type="rs" ID="2125376009" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001330700.2(TOP2B):c.1776_1778del (p.Glu593del) AND B-cell immunodeficiency, distal limb anomalies, and urogenital malformations" Accession="RCV001775185" Version="1">
        <ClassifiedConditionList TraitSetID="70358">
          <ClassifiedCondition DB="MedGen" ID="C1836437">B-cell immunodeficiency, distal limb anomalies, and urogenital malformations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-11-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-11" MostRecentSubmission="2021-11-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21204224</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31409799</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33459963</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="70358" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">B-cell immunodeficiency, distal limb anomalies, and urogenital malformations</ElementValue>
                <XRef ID="MONDO:0012243" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOFFMAN SYNDROME</ElementValue>
                <XRef Type="MIM" ID="609296" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BILU SYNDROME</ElementValue>
                <XRef Type="MIM" ID="609296" DB="OMIM" />
              </Name>
              <XRef ID="C1836437" DB="MedGen" />
              <XRef ID="MONDO:0012243" DB="MONDO" />
              <XRef Type="MIM" ID="609296" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3950086" SubmissionDate="2021-11-04" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="126431.0001_B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS" title="TOP2B, 3-BP DEL, 1761AGA_B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS" />
        <ClinVarAccession Accession="SCV002011837" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a mother and daughter (family 1) with B-cell immunodeficiency, distal limb anomalies, and urogenital malformations (BILU; 609296) previously reported by Hugle et al. (2011), Broderick et al. (2019) identified a heterozygous 3-bp in-frame deletion (c.1761_1763delAGA) in the TOP2B gene, resulting in the deletion of a residue (Glu587del, E587del) in the TOPRIM domain. The mutation was found by exome sequencing and confirmed by Sanger sequencing. Yeast complementation studies indicated that the mutation caused a loss of function with a dominant-negative effect. Mice carrying a heterozygous E587del mutation recapitulated the BILU phenotype. They had impaired antibody response associated with defects in B-cell development and function, decreased expression of B-cell transcription factors Pax5 (167414) and Foxo1 (136533), and increased DNA breaks limited to B cells. T-cell proliferation and function was normal. The authors referred to the mutation as EE587E.</Attribute>
              <Citation>
                <ID Source="PubMed">21204224</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">31409799</ID>
              </Citation>
              <XRef DB="OMIM" ID="609296" Type="MIM" />
              <XRef DB="OMIM" ID="167414" Type="MIM" />
              <XRef DB="OMIM" ID="136533" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 13-year-old boy with BILU, Erdos et al. (2021) identified a de novo heterozygous c.1761delAGA mutation in the TOP2B gene. The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing. Functional studies of the variant were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">33459963</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TOP2B" />
          </GeneList>
          <Name>TOP2B, 3-BP DEL, 1761AGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1761AGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="126431.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3950086" TraitType="Disease" MappingType="Name" MappingValue="B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS" MappingRef="Preferred">
        <MedGen CUI="C1836437" Name="B-cell immunodeficiency, distal limb anomalies, and urogenital malformations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

